The 33rd Annual J.P. Morgan Healthcare Conference & Biotech Showcase was held in January in San Francisco, Calif. The conference is the biggest health care investing event of the year, attracting thousands of medical device, biotechnology, and pharmaceutical executives and investors in attendance from around the world. Numerous Israeli companies participated in the conference, including a group of seven health care technology companies that presented at the Health Evolution Summit, “Connecting Health Leaders.”

More than 30 Greenberg Traurig attorneys from offices around the world attended the conference to provide support to existing clients and forge new connections. In attendance from the firm’s Israel Practice were  Bob Grossman, co-chair of the Israel Practice, David Dykeman, co-chair of the firm’s Life Sciences & Medical Technology Group, and  Roman Fayerberg, an IP shareholder in the Boston office.

This year, Greenberg Traurig also offered a workshop on Maximizing Value in Partnering Deals. The workshop provided a comprehensive framework for the deal-making process in the life sciences and medical technology industries, including topics such as deal preparation and valuation, partner selection, and best practices for executing deals.Panelists from the United States and Europe also discussed common pitfalls and challenges in partnering deals. The workshop was followed by a networking reception attended by over 300 industry executives and investors.